Also known as AF-2139, Rev-Eyes®, 5,6,7,8-Tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine, Dapiprazol, Dapiprazolum, 5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine
Dapiprazole (brand name Rev-Eyes) is an alpha-1 blocker. It is used to reverse mydriasis after eye examination.
{{Drugbox | Verifiedfields = changed | verifiedrevid = 460112976 | IUPAC_name = 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,5-a]pyridine | image = Dapiprazole.svg | image_class = skin-invert-image
| tradename = | Drugs.com = | MedlinePlus = a601043 | pregnancy_category = B | legal_status = Rx-only | routes_of_administration = Topical (eye drops)
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).